NewslettersCell Therapy NewsUncategorizedNeurocognitive and Hypokinetic Movement Disorder with Features of Parkinsonism after BCMA-Targeting CAR-T Cell TherapyBy Justin.choi - December 10, 20210191Public transcriptomic datasets confirmed B cell maturation antigen (BCMA) RNA expression in the caudate of normal human brains, suggesting that this may be an on-target effect of anti-BCMA therapy.[Nature Medicine] 6445212 AAAAAAAA items 1 apa 0 default asc 1 169926 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article